Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
By D. Paterson, S. Swindells, Jeffrey A. Mohr, M. Brester, E. Vergis, C. Squier, M. Wagener, Nina Singh. 2000
3,597 citations recorded by the source corpus.
Subfields: Emergency Medicine, Family Practice, Infectious Diseases
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
Citations in the corpus
- Beyond Sparsity: Tree Regularization of Deep Models for Interpretability (2017, background): “We hope interpretable predictive models for adherence could help assess a patient’s overall prognosis (Paterson et al. 2000) and offer opportunities for intervention (e.”
- Self-Report Measures of Antiretroviral Therapy Adherence: A Review with Recommendations for HIV Research and Clinical Management (2006, methodology): “An abundance of convergent empirical evidence has confirmed that strict adherence to medication regimens is key to the successful treatment of HIV infection with antiretroviral therapy or ART (Bangsberg et al., 2000; Hogg et al., 2002; Paterson et al., 2000).”
- Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse (2004, background): “response [2–4], with some studies suggesting that adherence rates of at least 90–95% are required for optimal viral suppression [4,5].”
- Role of depression, stress, and trauma in HIV disease progression. (2008, background): “Furthermore, studies also link depression to premature HAART discontinuation and HAART nonadherence (32,50–52)—factors associated with poor health outcome (53).”
- Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators (2006, background): “Research indicates that consistently high levels of adherence are necessary for reliable viral suppression [6,7] and prevention of resistance [8], disease progression [9], and death [10].”
- A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors (2001, methodology): “When measured adherence from MEMS, pill count, or interview was missing, we examined the distribution of adherence measured by CAS, including mean adherence and the percentage of patients with a CAS lower than the clinically important cutoffs of 85% and 95% ( 7 ).”
- Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis (2013, background): “Introduction Adherence to HIV antiretroviral therapy (ART) is a critical determinant of HIV-1 RNA viral suppression and health outcomes [1 3].”